Part of the Eczema Knowledge Library
A Closer Look at the Inflammatory Pathways in Skin Conditions: An Ayurvedic Perspective
Inflammatory pathways are central to the development and exacerbation of various skin conditions, including acne, eczema, and more complex diseases like psoriasis and atopic dermatitis. From an Ayurvedic viewpoint, these conditions are driven by imbalances in the body’s Pitta, Vata, and sometimes Kapha doshas. Understanding the inflammatory mechanisms from both biological and Ayurvedic perspectives allows for a holistic approach to managing and preventing these skin conditions (Patwardhan et al., 2015).
In Ayurveda, the primary goal is not just to address symptoms but to treat the root cause of inflammation by pacifying aggravated doshas, detoxifying the body, and restoring internal balance. This approach aligns with the understanding that skin health is deeply connected to the body’s internal energies and digestive system (Sengupta et al., 2010).
Inflammatory Pathways in Skin Conditions
Inflammation in Skin: An Ayurvedic Understanding
From an Ayurvedic perspective, inflammation is often the result of an imbalance in Pitta dosha, which governs heat, metabolism, and digestion. When Pitta is aggravated, the excess heat manifests as skin conditions marked by redness, swelling, and irritation (Jurenka, 2009). Vata dosha can also play a role, especially in conditions characterized by dryness and cracking of the skin. In some cases, Kapha dosha contributes to skin conditions by causing blockages, leading to conditions like acne where excess oil and toxins accumulate (Sengupta et al., 2010).
Ayurveda’s approach to inflammation is holistic, focusing on the long-term pacification of aggravated doshas, promoting detoxification, and restoring harmony between body and mind. This differs from the modern medical focus on suppressing inflammation with drugs, which may address symptoms but not the root cause (Patwardhan et al., 2015).
Key Inflammatory Pathways in Skin Conditions: Ayurvedic View
Pathophysiological Processes in Specific Skin Conditions
Ayurveda offers insights into how the aggravation of doshas results in the chronic inflammatory pathways observed in common skin conditions:
Ayurvedic Strategies to Manage Inflammatory Pathways in Skin Conditions
Long-Term Ayurvedic Management of Skin Conditions
Ayurveda promotes a holistic and sustainable approach to managing skin conditions. The focus is not on immediate symptom relief but on long-term remission by bringing the body and mind into balance (Patwardhan et al., 2015).
Conclusion: A Holistic Approach to Inflammatory Skin Conditions
Ayurveda’s approach to managing inflammatory skin conditions offers a holistic perspective that focuses on the root causes of imbalance. By calming the Pitta and Vata doshas, detoxifying the body, and incorporating lifestyle changes to reduce stress, Ayurveda provides a sustainable path to managing chronic skin conditions. Through this long-term, balanced approach, individuals can achieve healthier skin and greater overall well-being (Patwardhan et al., 2015).
References
Waggoner S.N. Circadian Rhythms in Immunity. Curr. Allergy Asthma Rep.2020;20:2. doi: 10.1007/s11882-020-0896-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Kabashima K., Honda T., Ginhoux F., Egawa G. The immunological anatomy of the skin. Nat. Rev. Immunol.2019;19:19–30. doi: 10.1038/s41577-018-0084-5. [PubMed] [CrossRef] [Google Scholar]
Dainichi T., Kitoh A., Otsuka A., Nakajima S., Nomura T., Kaplan D.H., Kabashima K. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat. Immunol.2018;19:1286–1298. doi: 10.1038/s41590-018-0256-2. [PubMed] [CrossRef] [Google Scholar]
Dainichi T., Matsumoto R., Mostafa A., Kabashima K. Immune Control by TRAF6-Mediated Pathways of Epithelial Cells in the EIME (Epithelial Immune Microenvironment) Front. Immunol.2019;10:1107. doi: 10.3389/fimmu.2019.01107. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Sawada Y., Gallo R.L. Role of Epigenetics in the Regulation of Immune Functions of the Skin. J. Investig. Dermatol.2021;141:1157–1166. doi: 10.1016/j.jid.2020.10.012. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Addolorato G., Parente A., de Lorenzi G., D’Angelo Di Paola M.E., Abenavoli L., Leggio L., Capristo E., De Simone C., Rotoli M., Rapaccini G.L., et al. Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature. Digestion.2003;68:9–12. doi: 10.1159/000073220. [PubMed] [CrossRef] [Google Scholar]
Barrea L., Macchia P.E., Tarantino G., Di Somma C., Pane E., Balato N., Napolitano M., Colao A., Savastano S. Nutrition: A key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. J. Transl. Med.2015;13:303. doi: 10.1186/s12967-015-0658-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J. Dermatol. Sci.2010;58:1–7. doi: 10.1016/j.jdermsci.2010.02.008. [PubMed] [CrossRef] [Google Scholar]
Afifi L., Danesh M.J., Lee K.M., Beroukhim K., Farahnik B., Ahn R.S., Yan D., Singh R.K., Nakamura M., Koo J., et al. Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey. Dermatol. Ther.2017;7:227–242. doi: 10.1007/s13555-017-0183-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
McInnes I.B., Behrens F., Mease P.J., Kavanaugh A., Ritchlin C., Nash P., Masmitja J.G., Goupille P., Korotaeva T., Gottlieb A.B., et al. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): A double-blind, parallel-group, randomised, active-controlled, phase 3b trial. Lancet.2020;395:1496–1505. doi: 10.1016/S0140-6736(20)30564-X. [PubMed] [CrossRef] [Google Scholar]
Reich K., Armstrong A.W., Langley R.G., Flavin S., Randazzo B., Li S., Hsu M.-C., Branigan P., Blauvelt A. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomised controlled trial. Lancet.2019;394:831–839. doi: 10.1016/S0140-6736(19)31773-8. [PubMed] [CrossRef] [Google Scholar]
Yoshiki R., Kabashima K., Honda T., Nakamizo S., Sawada Y., Sugita K., Yoshioka H., Ohmori S., Malissen B., Tokura Y., et al. IL-23 from Langerhans Cells Is Required for the Development of Imiquimod-Induced Psoriasis-Like Dermatitis by Induction of IL-17A-Producing γδ T Cells. J. Investig. Dermatol.2014;134:1912–1921. doi: 10.1038/jid.2014.98. [PubMed] [CrossRef] [Google Scholar]
Liu T., Li S., Ying S., Tang S., Ding Y., Li Y., Qiao J., Fang H. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside. Front. Immunol.2020;11:594735. doi: 10.3389/fimmu.2020.594735. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Bissonnette R., Luger T., Thaçi D., Toth D., Messina I., You R., Guana A., Fox T., Papavassilis C., Gilloteau I., et al. Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: Results from a double-blind extension study. Br. J. Dermatol.2017;177:1033–1042. doi: 10.1111/bjd.15706. [PubMed] [CrossRef] [Google Scholar]
Saunte D., Mrowietz U., Puig L., Zachariae C. Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management. Br. J. Dermatol.2017;177:47–62. doi: 10.1111/bjd.15015. [PubMed] [CrossRef] [Google Scholar]
Egawa G., Kabashima K. Barrier dysfunction in the skin allergy. Allergol. Int.2018;67:3–11. doi: 10.1016/j.alit.2017.10.002. [PubMed] [CrossRef] [Google Scholar]
Medically reviewed by Dr. Adil Moulanchikkal, Lead Ayurveda Specialist at EliteAyurveda Clinics, with over 15 years of experience in treating neurological, skin, and autoimmune diseases.
Contact Us
At EliteAyurveda Specialist Clinic, we have a panel of specialists in various medical domains, including endocrine, autoimmune & dermatology. We are renowned for our multifaceted and root-cause approach to treating chronic and difficult-to-treat disorders.
Visit our website to learn more about individualized treatment plans based on Ayurvedic principles. Connect with us to get patient testimonials and speak directly with our patients about their experiences with our treatments.
Note: This article is for informational purposes only and is not a substitute for professional medical advice.
Related-
Know More About Ayurveda Treatments for Dermatology.
GET IN TOUCH
Contact us
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.